Revascularization of Occluded Right Coronary Artery and Outcome After Coronary Artery Bypass Grafting.


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
09 2023
Historique:
medline: 7 9 2023
pubmed: 4 2 2023
entrez: 3 2 2023
Statut: ppublish

Résumé

The aim of the present study was to evaluate the results of isolated coronary artery bypass grafting (CABG) with or without revascularization of the occluded right coronary artery (RCA). Patients undergoing isolated CABG were included in a prospective European multicenter registry. Outcomes were adjusted for imbalance in preoperative variables with propensity score matching analysis. Late outcomes were evaluated with Kaplan-Meier's method and competing risk analysis. Out of 2,948 included in this registry, 724 patients had a total occlusion of the RCA and were the subjects of this analysis. Occluded RCA was not revascularized in 251 (34.7%) patients with significant variability between centers. Among 245 propensity score-matched pairs, patients with and without revascularization of occluded RCA had similar early outcomes. The nonrevascularized RCA group had increased rates of 5-year all-cause mortality (17.7 vs. 11.7%, In this multicenter study, one-third of totally occluded RCAs was not revascularized during isolated CABG for multivessel coronary artery disease. Failure to revascularize an occluded RCA in these patients increased the risk of all-cause mortality and MACCEs at 5 years.

Identifiants

pubmed: 36736367
doi: 10.1055/s-0043-1761625
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

462-468

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Fausto Biancari (F)

Hear and Lung Center, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Department of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland.
Department of Medicine, University of Helsinki, South-Karelia Central Hospital, Lappeenranta, Finland.

Magnus Dalén (M)

Department of Molecular Medicine and Surgery and Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Tuomas Tauriainen (T)

Hear and Lung Center, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Department of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland.

Giuseppe Gatti (G)

Division of Cardiac Surgery, Cardio-Thoracic and Vascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.

Antonio Salsano (A)

Division of Cardiac Surgery, Ospedale Policlinico San Marino, University of Genoa, Genoa, Italy.

Francesco Santini (F)

Division of Cardiac Surgery, Ospedale Policlinico San Marino, University of Genoa, Genoa, Italy.

Marisa De Feo (M)

Department of Cardiothoracic Sciences, University of Campania "Luigi Vanvitelli," Monaldi Hospital, Naples, Italy.

Qiyao Zhang (Q)

Department of Molecular Medicine and Surgery and Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Enzo Mazzaro (E)

Division of Cardiac Surgery, Cardio-Thoracic and Vascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.

Ilaria Franzese (I)

Division of Cardiac Surgery, Cardio-Thoracic and Vascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.

Ciro Bancone (C)

Department of Cardiothoracic Sciences, University of Campania "Luigi Vanvitelli," Monaldi Hospital, Naples, Italy.

Marco Zanobini (M)

Cardiovascular Department, IRCCS Centro Cardiologico Monzino, Milan, Italy.

Timo Mäkikallio (T)

Department of Medicine, University of Helsinki, South-Karelia Central Hospital, Lappeenranta, Finland.

Matteo Saccocci (M)

Cardiac Surgery Unit, Poliambulanza Foundation, Brescia, Italy.

Alessandra Francica (A)

Division of Cardiac Surgery, University of Verona Medical School, Verona, Italy.

Francesco Onorati (F)

Division of Cardiac Surgery, University of Verona Medical School, Verona, Italy.

Zein El-Dean (Z)

Department of Cardiovascular Sciences, Clinical Sciences Wing, University of Leicester, Glenfield Hospital, Leicester, United Kingdom.

Giovanni Mariscalco (G)

Department of Cardiovascular Sciences, Clinical Sciences Wing, University of Leicester, Glenfield Hospital, Leicester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH